If the completion date was changed from June 2014 to June 2011, was this an extension? Or was it designed to cut three years off the completion date.
Can it be that the original 2014 date was by design, just in case the primary endpoint was not met and the company wants to meet the secondary endpoint (OS) to have the drug approved.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.